Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory S Merrick

Showing results (101-110 of 187) with videos related to

Pageof 19
Sort By:
Brachytherapy|March 23, 2012
Long-term outcome for very high-risk prostate cancer treated primarily with a triple modality approach to include permanent interstitial brachytherapyNathan Bittner, Gregory S Merrick, Wayne M Butler, et al.
BJU International|March 6, 2010
Relationship between prostate cancer mortality and number of unfavourable risk factors in men treated with definitive brachytherapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
BJU International|December 13, 2005
Severity categories of the International Prostate Symptom Score before, and urinary morbidity after, permanent prostate brachytherapySarah Gutman, Gregory S Merrick, Wayne M Butler, et al.
BJU International|August 17, 2010
Prostate cancer death is unlikely in high-risk patients following quality permanent interstitial brachytherapyGregory S Merrick, Wayne M Butler, Robert W Galbreath, et al.
Brachytherapy|December 31, 2010
The correlation between annular treatment margins and biochemical failure in prostate brachytherapy patients with optimized intraprostatic dosimetryNathan Bittner, Gregory S Merrick, Wayne M Butler, et al.
Brachytherapy|April 6, 2004
Prostate-specific antigen (PSA) velocity and benign prostate hypertrophy predict for PSA spikes following prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
International Journal of Radiation Oncology, Biology, Physics|April 18, 2002
Erectile function after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Robert W Galbreath, et al.
Brachytherapy|June 9, 2015
Is supplemental external beam radiation therapy necessary for patients with higher risk prostate cancer treated with 103Pd? Results of two prospective randomized trialsGregory S Merrick, Kent E Wallner, Robert W Galbreath, et al.
Urology|January 26, 2005
Influence of body mass index on biochemical outcome after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
International Journal of Radiation Oncology, Biology, Physics|February 28, 2003
Dysuria after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Pageof 19

Showing results (101-110 of 187) with videos related to

Sort By:
Pageof 19
Brachytherapy|March 23, 2012
Long-term outcome for very high-risk prostate cancer treated primarily with a triple modality approach to include permanent interstitial brachytherapyNathan Bittner, Gregory S Merrick, Wayne M Butler, et al.
BJU International|March 6, 2010
Relationship between prostate cancer mortality and number of unfavourable risk factors in men treated with definitive brachytherapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
BJU International|December 13, 2005
Severity categories of the International Prostate Symptom Score before, and urinary morbidity after, permanent prostate brachytherapySarah Gutman, Gregory S Merrick, Wayne M Butler, et al.
BJU International|August 17, 2010
Prostate cancer death is unlikely in high-risk patients following quality permanent interstitial brachytherapyGregory S Merrick, Wayne M Butler, Robert W Galbreath, et al.
Brachytherapy|December 31, 2010
The correlation between annular treatment margins and biochemical failure in prostate brachytherapy patients with optimized intraprostatic dosimetryNathan Bittner, Gregory S Merrick, Wayne M Butler, et al.
Brachytherapy|April 6, 2004
Prostate-specific antigen (PSA) velocity and benign prostate hypertrophy predict for PSA spikes following prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
International Journal of Radiation Oncology, Biology, Physics|April 18, 2002
Erectile function after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Robert W Galbreath, et al.
Brachytherapy|June 9, 2015
Is supplemental external beam radiation therapy necessary for patients with higher risk prostate cancer treated with 103Pd? Results of two prospective randomized trialsGregory S Merrick, Kent E Wallner, Robert W Galbreath, et al.
Urology|January 26, 2005
Influence of body mass index on biochemical outcome after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
International Journal of Radiation Oncology, Biology, Physics|February 28, 2003
Dysuria after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Pageof 19